	Correction: TET2 gene mutation status associated with poor prognosis of transition zone prostate cancer: a retrospective cohort study based on whole exome sequencing and machine learning models. Front Endocrinol (Lausanne) Wang Y, Yu A, Gao Z, Yuan X, Du X, Shi P, Guan H, Wen S, Wang H, Wang L, Fan B, Liu Z. PMID: 41450576 [PubMed - in process]
	Community Understanding and Attitudes Toward Prostate-Specific Antigen (PSA) Testing for Prostate Cancer Screening: A Cross-Sectional Survey Study From Saudi Arabia. Cureus Alkhars AF, Almaghlouth AK, Almusalem NF, Alaboud MS, Alshafei AB, Al Janobi MS, Al Watyan HA, Alramadhan HM, Alramadhan HA. PMID: 41450362 [PubMed]
	Clinical efficacy of apalutamide in Asian patients with metastatic castration-sensitive prostate cancer: Bayesian reanalysis of the TITAN trial. Jpn J Clin Oncol Chen W, Yoshida S, Hirakawa A, Sato H, Yajima S, Kobayashi M, Fujiwara M, Fukushima H, Arita Y, Waseda Y, Tanaka H, Masuda H, Fujii Y. PMID: 41450247 [PubMed - as supplied by publisher]
	Effects of Prior Local Therapy by Radical Prostatectomy or Radiotherapy on the Efficacy and Quality of Life of Patients Treated With Darolutamide in ARAMIS. Cancer Med Saar M, Fizazi K, Shore ND, Smith M, Damber JE, Semenov A, Ribal MJ, Birtle A, Rigaud J, Wallis CJD, Grimm MO, Halabi S, Armstrong AJ, Mohamed AF, Adorjan P, Srinivasan S, Verholen F, Morgans AK, Siemens DR. PMID: 41450200 [PubMed - indexed for MEDLINE]
	Predictive Factors for Gastrointestinal and Hepatic Adverse Events During 5-Aminolevulinic Acid-Guided Photodynamic Diagnosis in Bladder Cancer: Exploratory Analysis of the Phase III SPP2C102 Trial. Int J Urol Taoka R, Fukuhara H, Miyake M, Kobayashi K, Ikeda A, Kanao K, Komai Y, Fujiwara R, Sato Y, Sugimoto M, Tsuzuki T, Fujimoto K, Inoue K, Oya M. PMID: 41449791 [PubMed - as supplied by publisher]
	Real-world efficacy of switching androgen receptor signaling inhibitor therapy following apalutamide discontinuation because of adverse events in advanced prostate cancer: a multicenter study. Jpn J Clin Oncol Tohi Y, Kato T, Fujiwara K, Hayashida Y, Matsuoka Y, Hirama H, Yano T, Tsunemori H, Arai H, Nomura I, Yamaoka N, Mashima T, Kohashiguchi K, Abe Y, Naito H, Okazoe H, Taoka R, Ueda N, Sugimoto M. PMID: 41449570 [PubMed - as supplied by publisher]
	Evaluation of INR101, a PSMA-Targeted (18)F PET Tracer, for suspected prostate cancer: A multicenter phase I/IIa trial with histopathologic confirmation. EJNMMI Res Yang J, Wan W, Zhang J, Zhang N, Yang X, Wang W, Ma H, Xu Y, Fu Z, Wang X, Liu Y, Wang M, Liu F, Guo Y, Liu Y, Zhang X. PMID: 41449298 [PubMed - as supplied by publisher]
	Prostate cancer diagnosis using sensitive and sophisticated machine learning classifiers based on non-invasive urinary RNA biomarkers (PCASSO). Sci Rep Goh H, Heo T, Kim J, Kim Y, Lim B, Woo MK, Choi KY, Kim CS, Kim J. PMID: 41449174 [PubMed - as supplied by publisher]
	Nivolumab plus docetaxel versus placebo plus docetaxel for androgen receptor pathway inhibitor-pretreated and chemotherapy-naive metastatic castration-resistant prostate cancer (CheckMate 7DX): a double-blind, randomised, phase 3 trial. Lancet Oncol Fizazi K, Saad F, Alonso-Gordoa T, , Barthélémy P, Voog E, Javier Cutuli H, Buchler T, Ye D, Castellano D, Kwiatkowski M, Arslan C, Richardet M, Alifrangis C, Goh JC, Vianna K, Han W, Hatano K, Todenhöfer T, Retz M, Srivastava A, Jin C, Gupta S, Trandafirescu G, Campos A, Lee CW, van Kooten Losio M, Subudhi SK. PMID: 41449150 [PubMed - indexed for MEDLINE]
	Retrospective validation of an artificial intelligence system for diagnostic assessment of prostate biopsies on the ProMort cohort: study protocol. BMJ Open Ji X, Zelic R, Aspegren O, Mulliqi N, Fiorentino M, Giunchi F, Molinaro L, Boman SE, Szolnoky K, Liu LX, Pettersson A, Vincent PH, Eklund M, Akre O, Kartasalo K. PMID: 41448704 [PubMed - indexed for MEDLINE]
	Attitudes and intentions toward prostate cancer screening among males in China: a qualitative study. Front Urol Hao S, Fang L, Du Y, Zheng J, Ou Y, Yu Z. PMID: 41445567 [PubMed]
	Orthotopic bladder cancer preclinical models: Comprehensive review and technique optimization. Bladder Cancer Hanlon T, D'Andrea VD, Stelter I, Bekele R, Zhou Y, Mouw KW. PMID: 41445566 [PubMed]
	Urinary Tumor DNA to Identify Candidates for Repeat Transurethral Resection in Non-Muscle-Invasive Bladder Cancer. Cancer Sci Xue Z, Qie Y, Shen C, Wu Z, Chen H, Lin Y, Li R, Huang S, Hu H. PMID: 41445362 [PubMed - as supplied by publisher]
	Histone deacetylase HDAC7 restricts CD8â€‰+â€‰T cell tumor infiltration and limits immunotherapy sensitivity in bladder cancer: reversal by pinocembrin. J Exp Clin Cancer Res Lv J, Li K, Zhou J, Yu R, Lu Q, Liu B. PMID: 41444923 [PubMed - indexed for MEDLINE]
	Unraveling diethyl phthalate-induced prostate carcinogenesis: core targets revealed by integrated network toxicology, machine learning, and structural validation. Hum Genomics Liu H, Jiang J, Tan Y, Yang M, Yang H, Li C. PMID: 41444679 [PubMed - indexed for MEDLINE]
	Nomograms based on SIRI for predicting postoperative survival outcomes in patients with non-metastatic clear cell renal cell carcinoma. BMC Surg Zhang B, Ren W, Yang T, Fan J, Han J, Yang H. PMID: 41444555 [PubMed - indexed for MEDLINE]
	Evaluation of [(89)Zr]Zr-girentuximab PET imaging of clear cell renal cell carcinoma in chinese patients: a Phase 1 clinical study (ZIRDOSE-CP). EJNMMI Res Liu C, Ji Y, Wu X, Cerqueira B, Cade D, Du P, Yang Z. PMID: 41444455 [PubMed - as supplied by publisher]
	Assessing clinical complete response after neoadjuvant systemic therapy in muscle-invasive bladder cancer: a systematic review. World J Urol Roessler N, Miszczyk M, Gontero P, Miyajima K, Inoue S, Alfarhan AR, Alqahtani AS, von Deimling M, Vetterlein MW, Teoh JY, D'Andrea D, Fisch M, Shariat SF. PMID: 41444445 [PubMed - in process]
	Enhanced classification prostate cancer based on generative adversarial networks and integrated deep learning with vision transformer models. Sci Rep Salama WM, Aly MH. PMID: 41444330 [PubMed - indexed for MEDLINE]
	RESECT: A Randomised Controlled Trial of Audit and Feedback in Non-muscle-invasive Bladder Cancer Surgery. Eur Urol Gallagher K, MacLennan S, Bhatt N, Clement K, Zimmermann E, Khadhouri S, Kulkarni M, Gaba MPhil F, Anbarasan T, Asif A, Light A, Ng A, Chan VW, Nathan A, Cooper D, Aucott L, Sakthivel D, Akand M, Piazza P, Marcq G, O'Brien T, Nielsen M, Giudice FD, Simpson K, Orecchia L, Teixeira B, Dawam D, Geisenhoff A, Hill G, Fukuokaya W, Hidalgo BG, El-Hajj A, Elgamal M, Fanshawe J, Wang B, Lee T, Manecksha R, McCann C, Rivas JG, Arda E, Elhadi M, Rossi S, Teoh JY, Mariappan P, Kasivisvanathan V, BURST-RESECT Global Study Group. PMID: 41444076 [PubMed - as supplied by publisher]

Articles 1 - 20 / 174802

Page 1 of 8741



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy